Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Erector Spinae Block With Ropivacaine and Dexmedetomidine in Lumbar Spine Surgeries
NCT05664542Phase 4Unknown
- Sponsor
- Security Forces Hospital
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Security Forces Hospital. Primary endpoint: 24 hours opioid consumption. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05664542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664542.